Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East
- PMID: 32851423
- PMCID: PMC7867556
- DOI: 10.1007/s00296-020-04682-6
Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East
Abstract
Globally, increasing demand for rheumatology services has led to a greater reliance on non-physician healthcare professionals (HCPs), such as rheumatology nurse specialists, to deliver care as part of a multidisciplinary team. Across Africa and the Middle East (AfME), there remains a shortage of rheumatology HCPs, including rheumatology nurses, which presents a major challenge to the delivery of rheumatology services, and subsequently the treatment and management of conditions such as rheumatoid arthritis (RA). To further explore the importance of nurse-led care (NLC) for patients with RA and create a set of proposed strategies for the implementation of NLC in the AfME region, we used a modified Delphi technique. A review of the global literature was conducted using the PubMed search engine, with the most relevant publications selected. The findings were summarized and presented to the author group, which was composed of representatives from different countries and HCP disciplines. The authors also drew on their knowledge of the wider literature to provide context. Overall, results suggest that NLC is associated with improved patient perceptions of RA care, and equivalent or superior clinical and cost outcomes versus physician-led care in RA disease management. Expert commentary provided by the authors gives insights into the challenges of implementing nurse-led RA care. We further report practical proposed strategies for the development and implementation of NLC for patients with RA, specifically in the AfME region. These proposed strategies aim to act as a foundation for the introduction and development of NLC programs across the AfME region.
Keywords: Africa; Middle East; Nurse-led care; Rheumatoid arthritis; Rheumatology disease management; Specialist nursing.
Conflict of interest statement
IU has received speaker fees from AbbVie, Janssen, Newbridge, and Pfizer Inc. HA has received research grants from AbbVie and Pfizer Inc, and honoraria/speaker fees from Lilly, Novartis, and Pfizer Inc. BM has received speaker fees from AbbVie, Amgen, Bikma, Janssen, Novartis, and Pfizer Inc. YED and NS are employees and shareholders of Pfizer Inc. KR has received honoraria/speaker fees from AbbVie, BMS, Janssen, Lilly, Pfizer Inc, Sanofi, and UCB; and research grants from Pfizer Inc. KK has received speaker fees from Pfizer Inc. IL is an advisory board member of Janssen, Novartis, Pfizer Inc, and Roche. CDB, CDM, HASH, NT, and OA declare that they have no competing interests.
Figures
Similar articles
-
Clinical effectiveness and cost-effectiveness of nurse-led care in Chinese patients with rheumatoid arthritis: A randomized trial comparing with rheumatologist-led care.Int J Nurs Pract. 2018 Feb;24(1). doi: 10.1111/ijn.12605. Epub 2017 Oct 26. Int J Nurs Pract. 2018. PMID: 29072362 Clinical Trial.
-
Experience of Patients With Rheumatoid Arthritis: A Qualitative Study of a Nurse-Led Clinic.Clin Nurs Res. 2023 May;32(4):840-849. doi: 10.1177/10547738231164395. Epub 2023 Mar 31. Clin Nurs Res. 2023. PMID: 36999603
-
The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial.Ann Rheum Dis. 2014 Nov;73(11):1975-82. doi: 10.1136/annrheumdis-2013-203403. Epub 2013 Aug 27. Ann Rheum Dis. 2014. PMID: 23982436 Free PMC article. Clinical Trial.
-
The patient perspective of nurse-led care in early rheumatoid arthritis: A systematic review of qualitative studies with thematic analysis.J Clin Nurs. 2021 Jan;30(1-2):145-160. doi: 10.1111/jocn.15531. Epub 2020 Oct 30. J Clin Nurs. 2021. PMID: 33125809
-
Effectiveness of nurse-led care in patients with rheumatoid arthritis: a systematic review and meta-analysis.BMJ Open Qual. 2025 Jan 4;14(1):e003037. doi: 10.1136/bmjoq-2024-003037. BMJ Open Qual. 2025. PMID: 39755563 Free PMC article.
Cited by
-
Healthcare Professionals' Compliance with the Standard Management Guidelines towards the Use of Biological Disease-Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients.Int J Environ Res Public Health. 2022 Apr 13;19(8):4699. doi: 10.3390/ijerph19084699. Int J Environ Res Public Health. 2022. PMID: 35457564 Free PMC article.
-
Flavonoids and flavonoid-based nanoparticles for the treatment of arthritis.Inflammopharmacology. 2025 May;33(5):2193-2216. doi: 10.1007/s10787-025-01722-0. Epub 2025 Mar 29. Inflammopharmacology. 2025. PMID: 40156677 Review.
-
Epidemiology of rheumatic and musculoskeletal diseases in a Nigerian peri-urban community: results of a cross-sectional survey using the COPCORD stage 1 model.Reumatologia. 2022;60(6):366-375. doi: 10.5114/reum.2022.123667. Epub 2022 Dec 30. Reumatologia. 2022. PMID: 36683835 Free PMC article.
-
[The low expression of long non-coding RNA Linc00638 contributes to rheumatoid arthritis progression by regulating inflammation and oxidative stress].Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jul 20;41(7):965-971. doi: 10.12122/j.issn.1673-4254.2021.07.01. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 34308844 Free PMC article. Chinese.
-
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic.Rheumatol Int. 2021 Jan;41(1):67-76. doi: 10.1007/s00296-020-04737-8. Epub 2020 Nov 4. Rheumatol Int. 2021. PMID: 33150493 Free PMC article.
References
-
- Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1316–1322. doi: 10.1136/annrheumdis-2013-204627. - DOI - PubMed
-
- Dahou-Makhloufi C, Mechid F, Benaziez R, Zehraoui N, Matari D, Haddam HT, Oussaid M, Achek M (2018) PT6C:096 Low rheumatoid arthritis prevalence in Algeria: a Mediterranean singularity? Clin Exp Rheumatol 1(Suppl 109):Abstract PT6C:096
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous